Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.5470_5484dup | p.Cys1824_Gly1829dup | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GGC | Gly | ins15a | InF | In frame ins | Fr. |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #26 | Domain-domain packing |
At the mRNA level | On restriction map |
Duplication of a repeated sequence | New restriction site(s): none Lost restriction site(s): none |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
BEL01GHE F0071 I1804 | Proband | Male | familial | 41 years old | BELGIUM |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Asc. aortic dilatation |
C-Mitral valve prolapse |
CF-Dolichocephaly |
CF-Down-slanting palpebral fissures |
CF-Malar hypoplasia |
CF-Retrognathia |
O-Flat cornea (<42 dp) (m) |
S-Arachnodactyly (M) |
S-Enophthalmos (m) |
S-Joint hypermobility (m) |
S-Scoliosis > 20° (M)(1) |
SI-Significant striae atrophicae (m)(1) |
Reference ID | PubMed ID | Reference |
89 | 11700157 | Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A. "Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome". Arch Intern Med. 2001 Nov 12;161(20):2447-54. |